Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 775. The contact email is not on this page.
- CELL REPROGRAMMING AND THERAPEUTICS, LLC
NIH R43: Novel Cell Culture Supplement from Adipocyte-Origin Megakaryocytes and Platelets
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PHARMAIN CORPORATION
NIH R44: Development of an immunomodulating peptide as a therapy for osteosarcoma in canine and human
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EYESCREEN, INC.
NIH R43: Drug Screening Platform in the Light-Responsive Human Eye
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Ksana Health
Ksana Health is a digital platform that transforms behavioral healthcare by providing personalized insights and just-in-time interventions to improve mental health outcomes.
startup · OR · amount not stated · 2022-09-06
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-09-06.
- DPLEXBIO INC.
NIH R44: Emulsion digital PCR
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KATE ALLYN PROSTHETIC RESEARCH
NIH R43: A novel pediatric prosthetic foot for functional multi-axial mobility during active play
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KALOCYTE, INC.
NIH R44: ErythroMer: Nanoscale BioSynthetic Red Cell Substitute
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EMMUNE, INC
NIH R44: SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CAMBIUM ONCOLOGY LLC
NIH R44: Development of a Novel Armored CAR-T Immunotherapeutic for Pancreatic Cancer
startup · GA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Absco Therapeutics, Inc.
Form D history: Biotechnology
startup · MA · amount not stated · 2025-08-27
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-08-27.
- ABVACC, INC.
NIH R44: Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NAJIT TECHNOLOGIES, INC.
NIH U44: A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus Vaccine
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VDF INDUSTRIES INC
NIH R41: Phonocath - An endovascular medical device to objectively evaluate Pulsatile Tinnitus
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EQUITI FOODS, LLC
NIH R41: Achieving health equity through food as medicine and medically tailored meals: local economic opportunity
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- REMBAC ENVIRONMENTAL, LLC
NIH R44: Development of an innovative approach for in situ treatment of PCB impacted sediments by microbial bioremediation
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- UP THERAPEUTICS, INC.
NIH R44: Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RITHIM BIOLOGICS, INC.
NIH R44: Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT
NIH R42: Care Assistant for Family Caregivers of Persons with Dementia During Out of the Home Activities
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VITAKEY, INC.
NIH R44: Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestines
startup · DC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- L2 DIAGNOSTICS, LLC
NIH R41: Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ScitoVation, LLC
Form D history: Biotechnology
startup · NC · amount not stated · 2020-10-05
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2020-10-05.
- MITEGEN, LLC
NIH R43: Improving cryopreservation outcomes of small biological samples through ultra-fast convective cooling and warming
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AO TECHNOLOGIES, LLC
NIH R41: Development of a high performance reduced cost OCT Otoscope
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENDONAVIS, LLC
NIH R43: Novel Over-the-Scope Platform for Control of Variceal Bleeding
startup · KY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Mitotherapeutix, LLC
Form D history: Biotechnology
startup · CT · amount not stated · 2025-05-22
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-05-22.
- CREARE, LLC
NIH R43: Wearable Sensor System for Continuous Monitoring of Alcohol Withdrawal Syndrome
startup · NH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- YOUNG THERAPEUTICS, LLC
NIH R44: Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004.
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GINER, INC.
NIH R44: Field Instrument for Assessment of Arsenic Exposure
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LOGICYTE, INC.
NIH R43: Automated Platform for Critical Quality Analytics in Cell Therapy Manufacturing
startup · GA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- JUNIPERO THERAPEUTICS, INC.
NIH R41: Epigenetic Silencing of VCP via an ASO-Conjugate Based Induced Proximity System for the Treatment of FTD-ALS in VCP Disease
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MicroVascular Tissues, Inc.
Form D history: Other Health Care
startup · MA · amount not stated · 2023-03-10
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-03-10.
- TWIN PEAKS BIO, INC.
NIH R41: Lead selection studies of novel antisense oligonucleotide for cancer immunotherapy
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ALELOPHARMA INC.
NIH R43: Ultra-precision diagnostics for ALK+ non-small cell lung cancer
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GLYCO DISCOVERIES, INC
NIH R42: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GLYCAN THERAPEUTICS CORPORATION
NIH R41: National I-Corps: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARNOLD CONSULTANCY AND TECHNOLOGY, LLC
NIH R43: Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEPHSMART LLC
NIH R41: A Device for Detection of Acute Kidney Injury
startup · AR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Solaris Vaccines, Inc.
Form D history: Other
startup · CO · amount not stated · 2023-05-19
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-05-19.
- SAMAY, INC.
NIH R43: Developing a novel, non-invasive wearable device for COPD diagnosis andMonitoring
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NUBAD, LLC
NIH R42: Development of peptide nucleic acid antibiotics
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.